Jeong Hyun Seo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jeong Hyun Seo has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Hyung Joon Cha
Department of Chemical Engineering, Pohang University of Science and Technology, Pohang, 37673, Republic of Korea; Medical Science and Engineering, School of Convergence Science and Technology, Pohang University of Science and Technology, Pohang, 37673, Republic of Korea
11 shared publications Young Hoon Song
School of Chemical Engineering, Yeungnam University, Gyeongsan, 38541, South Korea
11 shared publicationsJeong Chan Park
Department of Chemical Engineering, Pohang University of Science and Technology, 77 Cheongam-Ro, Nam-Gu, Pohang, Gyeongbuk 37673, Korea
8 shared publicationsChang Sup Kim
Yeungnam University
6 shared publications- Chang Sup Kim
Department of Chemical and Biochemical Engineering, Dongguk University, Seoul, Republic of Korea
6 shared publications - Kye-Il Joo
Department of Chemical Engineering & Materials Science Ewha Womans University Seoul Republic of Korea
6 shared publications
Latest Publications
- 18 January 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 343  (Pt 2) , 150364
Analysis of the antibacterial mechanism of Levan against Escherichia coli using differential gene expression analysis and electron microscopy
- 18 January 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 343  (Pt 2) , 150364
Analysis of the antibacterial mechanism of Levan against Escherichia coli using differential gene expression analysis and electron microscopy
- 2 July 2025
- Published by Elsevier in Biotechnology Advances
- Vol. 83, 108635
Exploiting glycan arrays and biosensors to diagnose and understand diseases
- 2 July 2025
- Published by Elsevier in Biotechnology Advances
- Vol. 83, 108635
Exploiting glycan arrays and biosensors to diagnose and understand diseases
- 9 April 2025
- Published by Springer Nature in Korean Journal of Chemical Engineering
- Vol. 42  (9) , 2123-2129
Cytotoxic Effects of Particulate Matter on Cell Growth and Metabolism of Green Fluorescent Protein-Expressing Escherichia coli
- 9 April 2025
- Published by Springer Nature in Korean Journal of Chemical Engineering
- Vol. 42  (9) , 2123-2129
Cytotoxic Effects of Particulate Matter on Cell Growth and Metabolism of Green Fluorescent Protein-Expressing Escherichia coli
- 30 January 2025
- Published by Elsevier in Carbohydrate Polymers
- Vol. 354, 123337
Bioadhesive levan-based coaxial nanofibrous membranes with enhanced cell adhesion and mesenchymal stem cell differentiation
- 30 January 2025
- Published by Elsevier in Carbohydrate Polymers
- Vol. 354, 123337
Bioadhesive levan-based coaxial nanofibrous membranes with enhanced cell adhesion and mesenchymal stem cell differentiation
- Open Access
Inclusion Complexation of Remdesivir with Cyclodextrins: A Comprehensive Review on Combating Coronavirus Resistance—Current State and Future Perspectives
Cyclodextrin (CD) derivatives have gained significant attention in biomedical applications due to their remarkable biocompatibility, unique inclusion capabilities, and potential for functionalization. This review focuses on recent advancements in CD-based assemblies, specifically their role in improving drug delivery, emphasizing remdesivir (RMD). The review introduces CD materials and their versatile applications in self-assembly and supramolecular assembly. CD materials offer immense potential for designing drug delivery systems with enhanced activity. Their inherent inclusion capabilities enable the encapsulation of diverse therapeutic agents, including RMD, resulting in improved solubility, stability, and bioavailability. The recent advances in CD-based assemblies, focusing on their integration with RMD have been concentrated here. Various strategies for constructing these assemblies are discussed, including physical encapsulation, covalent conjugation, and surface functionalization techniques. Furthermore, exploring future directions in these fields has also been provided. Ongoing research efforts are directed toward developing novel CD derivatives with enhanced properties, such as increased encapsulation efficiency and improved release kinetics. Moreover, the integration of CD-based assemblies with advanced technologies such as nanomedicine and gene therapy holds tremendous promise for personalized medicine and precision therapeutics
Open AccessInclusion Complexation of Remdesivir with Cyclodextrins: A Comprehensive Review on Combating Coronavirus Resistance—Current State and Future Perspectives
Cyclodextrin (CD) derivatives have gained significant attention in biomedical applications due to their remarkable biocompatibility, unique inclusion capabilities, and potential for functionalization. This review focuses on recent advancements in CD-based assemblies, specifically their role in improving drug delivery, emphasizing remdesivir (RMD). The review introduces CD materials and their versatile applications in self-assembly and supramolecular assembly. CD materials offer immense potential for designing drug delivery systems with enhanced activity. Their inherent inclusion capabilities enable the encapsulation of diverse therapeutic agents, including RMD, resulting in improved solubility, stability, and bioavailability. The recent advances in CD-based assemblies, focusing on their integration with RMD have been concentrated here. Various strategies for constructing these assemblies are discussed, including physical encapsulation, covalent conjugation, and surface functionalization techniques. Furthermore, exploring future directions in these fields has also been provided. Ongoing research efforts are directed toward developing novel CD derivatives with enhanced properties, such as increased encapsulation efficiency and improved release kinetics. Moreover, the integration of CD-based assemblies with advanced technologies such as nanomedicine and gene therapy holds tremendous promise for personalized medicine and precision therapeutics
- 20 April 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16  (17) , 21509-21521
Electrosprayable Levan-Coated Nanoclusters and Ultrasound-Responsive Drug Delivery for Cancer Therapy
In this study, we synthesized levan shell hydrophobic silica nanoclusters encapsulating doxorubicin (L-HSi-Dox) and evaluated their potential as ultrasound-responsive drug delivery systems for cancer treatment. L-HSi-Dox nanoclusters were successfully fabricated by integrating a hydrophobic silica nanoparticle-doxorubicin complex as the core and an amphiphilic levan carbohydrate polymer as the shell by using an electrospray technique. Characterization analyses confirmed the stability, size, and composition of the nanoclusters. In particular, the nanoclusters exhibited a controlled release of Dox under aqueous conditions, demonstrating their potential as efficient drug carriers. The levanic groups of the nanoclusters enhanced the targeted delivery of Dox to specific cancer cells. Furthermore, the synergism between the nanoclusters and ultrasound effectively reduced cell viability and induced cell death, particularly in the GLUT5-overexpressing MDA-MB-231 cells. In a tumor xenograft mouse model, treatment with the nanoclusters and ultrasound significantly reduced the tumor volume and weight without affecting the body weight. Collectively, these results highlight the potential of the L-HSi-Dox nanoclusters and ultrasound as promising drug delivery systems with an enhanced therapeutic efficacy for biomedical applications.
- 20 April 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16  (17) , 21509-21521
Electrosprayable Levan-Coated Nanoclusters and Ultrasound-Responsive Drug Delivery for Cancer Therapy
In this study, we synthesized levan shell hydrophobic silica nanoclusters encapsulating doxorubicin (L-HSi-Dox) and evaluated their potential as ultrasound-responsive drug delivery systems for cancer treatment. L-HSi-Dox nanoclusters were successfully fabricated by integrating a hydrophobic silica nanoparticle-doxorubicin complex as the core and an amphiphilic levan carbohydrate polymer as the shell by using an electrospray technique. Characterization analyses confirmed the stability, size, and composition of the nanoclusters. In particular, the nanoclusters exhibited a controlled release of Dox under aqueous conditions, demonstrating their potential as efficient drug carriers. The levanic groups of the nanoclusters enhanced the targeted delivery of Dox to specific cancer cells. Furthermore, the synergism between the nanoclusters and ultrasound effectively reduced cell viability and induced cell death, particularly in the GLUT5-overexpressing MDA-MB-231 cells. In a tumor xenograft mouse model, treatment with the nanoclusters and ultrasound significantly reduced the tumor volume and weight without affecting the body weight. Collectively, these results highlight the potential of the L-HSi-Dox nanoclusters and ultrasound as promising drug delivery systems with an enhanced therapeutic efficacy for biomedical applications.
- 9 March 2024
- Published by Springer Nature in Biotechnology and Bioprocess Engineering
- Vol. 29  (2) , 329-338
Reinforced levan-based electrospun nanofibers for application as adhesive scaffolds for tissue engineering
- 9 March 2024
- Published by Springer Nature in Biotechnology and Bioprocess Engineering
- Vol. 29  (2) , 329-338
Reinforced levan-based electrospun nanofibers for application as adhesive scaffolds for tissue engineering
- 24 March 2023
- Published by Springer Nature in Korean Journal of Chemical Engineering
- Vol. 40  (7) , 1709-1714
Utilization of functionalized silane coatings for enhanced mechanical properties of hydroxyapatite filler
- 24 March 2023
- Published by Springer Nature in Korean Journal of Chemical Engineering
- Vol. 40  (7) , 1709-1714
Utilization of functionalized silane coatings for enhanced mechanical properties of hydroxyapatite filler
- 15 December 2022
- Published by Springer Nature in Cellulose
- Vol. 30  (3) , 1685-1696
Development of mechanically reinforced bioadhesive electrospun nanofibers using cellulose acetate–levan complexes
- 15 December 2022
- Published by Springer Nature in Cellulose
- Vol. 30  (3) , 1685-1696
Development of mechanically reinforced bioadhesive electrospun nanofibers using cellulose acetate–levan complexes
- Open Access
- 26 May 2021
- Published by Springer Nature in Research Square
Glycan chip based on structure switchable DNA linker for on-chip biosynthesis of cancer-associated complex glycans
On-chip glycan biosynthesis is an effective strategy for preparing useful complex glycan sources and for preparing glycan-involved applications simultaneously. However, current methods have some limitations when analyzing biosynthesized glycans and optimizing enzymatic reactions, which could result in undefined glycan structures on a surface, leading to unequal and unreliable results. In this work, a novel glycan chip was developed by introducing a pH-responsive i-motif DNA linker to control the immobilization and isolation of glycans on chip surfaces in a pH-dependent manner. On-chip enzymatic glycosylations were optimized for uniform biosynthesis of cancer-associated Globo H hexasaccharide and its related complex glycans through stepwise quantitative analyses of isolated products from the surface. Successful interaction analyses of the anti-Globo H antibody and MCF-7 breast cancer cells with on-chip biosynthesized Globo H-related glycans demonstrated the feasibility of the structure-switchable DNA linker-based glycan chip platform for on-chip complex glycan biosynthesis and glycan-involved applications.
- 26 May 2021
- Published by Springer Nature in Research Square
Open AccessGlycan chip based on structure switchable DNA linker for on-chip biosynthesis of cancer-associated complex glycans
On-chip glycan biosynthesis is an effective strategy for preparing useful complex glycan sources and for preparing glycan-involved applications simultaneously. However, current methods have some limitations when analyzing biosynthesized glycans and optimizing enzymatic reactions, which could result in undefined glycan structures on a surface, leading to unequal and unreliable results. In this work, a novel glycan chip was developed by introducing a pH-responsive i-motif DNA linker to control the immobilization and isolation of glycans on chip surfaces in a pH-dependent manner. On-chip enzymatic glycosylations were optimized for uniform biosynthesis of cancer-associated Globo H hexasaccharide and its related complex glycans through stepwise quantitative analyses of isolated products from the surface. Successful interaction analyses of the anti-Globo H antibody and MCF-7 breast cancer cells with on-chip biosynthesized Globo H-related glycans demonstrated the feasibility of the structure-switchable DNA linker-based glycan chip platform for on-chip complex glycan biosynthesis and glycan-involved applications.